Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $25.1 million.

  • Veracyte's Other Operating Expenses rose 591.29% to $25.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.0 million, marking a year-over-year decrease of 500.11%. This contributed to the annual value of $102.1 million for FY2024, which is 4062.11% down from last year.
  • Latest data reveals that Veracyte reported Other Operating Expenses of $25.1 million as of Q3 2025, which was up 591.29% from $46.4 million recorded in Q2 2025.
  • Over the past 5 years, Veracyte's Other Operating Expenses peaked at $59.8 million during Q3 2023, and registered a low of -$64.6 million during Q4 2022.
  • For the 5-year period, Veracyte's Other Operating Expenses averaged around $35.3 million, with its median value being $40.9 million (2021).
  • As far as peak fluctuations go, Veracyte's Other Operating Expenses plummeted by 22781.4% in 2022, and later soared by 18946.98% in 2023.
  • Veracyte's Other Operating Expenses (Quarter) stood at $50.6 million in 2021, then crashed by 227.81% to -$64.6 million in 2022, then soared by 189.47% to $57.8 million in 2023, then crashed by 50.93% to $28.4 million in 2024, then decreased by 11.63% to $25.1 million in 2025.
  • Its last three reported values are $25.1 million in Q3 2025, $46.4 million for Q2 2025, and $25.1 million during Q1 2025.